Abstract
According to previous data, pretreatment albumin-to-globulin ratio (AGR) was a simplified biomarker that was an independent prognostic factor in lung cancer, but there are no data on the use of AGR as a prognostic factor in metastatic non-small cell lung cancer (NSCLC) treated with chemotherapy. The aim of this study was to determine whether AGR can be used as a prognostic factor under these conditions.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
